Download Docs
Export
Print

SALVAGENIX

99393012 | Trademark citeCite Docket

Interested in this case?

To schedule a demo, contact us at sales@docketalarm.com. Track this case, and find millions of cases like it, let us show you how.
Filed Sept. 15, 2025
Serial No. 99393012
Examining Attorney CHRISTOPHER M LAW
Class Pharmaceutical preparations for the treatment of digoxin, digitalis or other cardio-active glycoside toxicity; Veterinary preparations for digoxin, digitalis or other cardio-active glycoside toxicity; Pharmaceutical preparations for the treatment of pre-eclampsia; Chemical reagents for medical or veterinary use; Pharmaceutical preparations for use in the treatment of digoxin, digitalis or other cardio-active glycoside toxicity, and for use in the treatment of pre-eclampsia; Chemical preparations for pharmaceutical or medical purposes, namely, for medicines for use in the treatment of digoxin, digitalis or other cardio-active glycoside toxicity and for use in the treatment of pre-eclampsia; Veterinary preparations for the treatment of pre-eclampsia; 005; 006; 018; 044; 046; 051; 052
SALVAGENIX
Case Type Trademark
Status Notice of Allowance (NOA) sent (issued) to the applicant. Applicant must file a Statement of Use or Extension Request within six months of the NOA issuance date.
Last Updated: 3 days, 19 hours ago
Filing Date # Docket Text
to view the full docket.